WHO Medical Product Alert: TETRACYCLINE HYDROCHLORIDE OPHTHALMIC
This WHO medical product alert refers to batches of TETRACYCLINE HYDROCHLORIDE OPHTHALMIC OINTMENT USP 1% manufactured by Galentic Pharma (India) Pvt. Ltd.
This ointment is usually indicated for use in bacterial blepharitis, bacterial conjunctivitis, bacterial keratitis, and trachoma.
However, five international procurers of the product independently conducted a visual examination of random samples of stock on hand and detected a range of quality issues. At least 55 countries have received the affected batches. WHO requests increased surveillance and diligence within the supply chains of countries and regions likely to be affected.
Read more below.